Developing world perspective of posttransplant tuberculosis: Morbidity, mortality, and cost implications

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 1787-1788

  Naqvi, A ^a   Rizvi, A ^a  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; ADULT; CONFERENCE PAPER; COST; DEVELOPING COUNTRY; FEMALE; GRAFT REJECTION; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; ORGAN TRANSPLANTATION; PAKISTAN; PRIORITY JOURNAL; SCHOOL CHILD; TUBERCULOSIS;

ADOLESCENT; ADULT; CHILD; COSTS AND COST ANALYSIS; DEVELOPING COUNTRIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MORBIDITY; PAKISTAN; RETROSPECTIVE STUDIES; TUBERCULOSIS; TUBERCULOSIS, GASTROINTESTINAL; TUBERCULOSIS, LYMPH NODE; TUBERCULOSIS, PULMONARY;

EID: 0035077238     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02680-4     Document Type: Conference Paper

References (4)

1. Naqvi A, Akhtar F, Naqvi R, et al: Transplant Proc 29:3051, 1997
2. Singh N, Paterson DL: Clin Infect Dis 27:1266, 1998
3. Sakhuja V, Jha V, Varma PP, et al: Transplantation 61:211, 1996
4. Singh N: Curr Opin Organ Transplant 4:281, 1999